GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.75
-0.46 (-0.90%)
Oct 23, 2026, 4:00 PM EDT - Market closed
GSK Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, GSK stock has a consensus rating of "Buy" and an average price target of $60.51. The average 1-year stock price forecast is 19.23% higher than the current stock price, while the lowest is $49 (-3.45%) and the highest is $70 (+37.93%).
Price Target: $60.51 (+19.23%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 16, 2026.
Analyst Ratings
The average analyst rating for GSK stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 1 | 1 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 8 | 7 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Berenberg Bank No rating | Berenberg Bank | Buy Upgrades $60 | Buy | Upgrades | $60 | +18.23% | Sep 16, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $70 | Hold | Maintains | $70 | +37.93% | Aug 3, 2026 |
| Argus Research | Argus Research | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $67 | Buy | Maintains | $67 | +32.22% | May 29, 2026 |
Financial Forecast
Revenue This Year
33.90B
from 32.67B
Increased by 3.76%
Revenue Next Year
35.51B
from 33.90B
Increased by 4.76%
EPS This Year
1.79
from 1.72
Increased by 4.24%
EPS Next Year
1.90
from 1.79
Increased by 6.01%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.